Jason K Garland Repligen Corp (RGEN) insider trading activity

Jason K Garland is CFO of REPLIGEN CORP. Currently has a direct ownership of 13,383 shares of RGEN, which is worth approximately $1.91 Million. The most recent transaction as insider was on Sep 25, 2025, when has been sold 412 shares (Common Stock) at a price of $121.68 per share, resulting in proceeds of $50,132. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.4K

2.99% 3M change

66.39% 12M change

Total Value Held $1.91 Million

Jason K Garland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 25 2025	SELL Payment of exercise price or tax liability	$50,132 $121.68 p/Share	412 Reduced 2.99%	13,383 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	6,435 Added 31.81%	13,795 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$49,466 $156.54 p/Share	316 Reduced 4.12%	7,360 Common Stock
Nov 20 2024	SELL Payment of exercise price or tax liability	$45,291 $123.41 p/Share	367 Reduced 4.56%	7,676 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	2,540 Added 24.0%	8,043 Common Stock
Sep 25 2023	BUY Grant, award, or other acquisition	-	5,503 Added 50.0%	5,503 Common Stock

Also insider at

ITGR

Integer Holdings Corp Healthcare

EVP, Chief Financial Officer

AFIB

Acutus Medical, Inc. Healthcare

Director

JKG

Jason K Garland

CFO

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account